Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirofiban Dosing in Complex Coronary Artery Disease
NCT02294994Phase 4Unknown
- Sponsor
- The Second Hospital of Jilin University
- Start
- Nov 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tirofiban in coronary artery disease (CAD), sponsored by The Second Hospital of Jilin University. Status: unknown.
02
Drugs
tirofiban
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02294994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02294994.